Cognitive heterogeneity reveals molecular signatures of age-related impairment.
Sreemathi LoganMatthew P BaierDaniel B OwenJohn PeasariKenneth L JonesRojina RanjitHannah P YarbroughAnthony M MasingaleSuyesha BhandariHeather C RiceMichael T KinterWilliam E SonntagPublished in: PNAS nexus (2023)
The greatest risk factor for cognitive decline is aging. The biological mechanisms for this decline remain enigmatic due, in part, to the confounding of normal aging mechanisms and those that contribute to cognitive impairment. Importantly, many individuals exhibit impaired cognition in age, while some retain functionality despite their age. Here, we establish a behavioral testing paradigm to characterize age-related cognitive heterogeneity in inbred aged C57BL/6 mice and reliably separate animals into cognitively "intact" (resilient) and "impaired" subgroups using a high-resolution home-cage testing paradigm for spatial discrimination. RNA sequencing and subsequent pathway analyses of cognitively stratified mice revealed molecular signatures unique to cognitively impaired animals, including transcriptional down-regulation of genes involved in mitochondrial oxidative phosphorylation (OXPHOS) and sirtuin ( Sirt1 and Sirt3 ) expression in the hippocampus. Mitochondrial function assessed using high-resolution respirometry indicated a reduced OXPHOS coupling efficiency in cognitively impaired animals with subsequent hippocampal analyses revealing an increase in the oxidative damage marker (3-nitrotyrosine) and an up-regulation of antioxidant enzymes (Sod2, Sod1, Prdx6, etc.). Aged-impaired animals also showed increased levels of IL-6 and TNF-α gene expression in the hippocampus and increased serum levels of proinflammatory cytokines, including IL-6. These results provide critical insight into the diversity of brain aging in inbred animals and reveal the unique mechanisms that separate cognitive resilience from cognitive impairment. Our data indicate the importance of cognitive stratification of aging animals to delineate the mechanisms underlying cognitive impairment and test the efficacy of therapeutic interventions.
Keyphrases
- cognitive decline
- cognitive impairment
- mild cognitive impairment
- single cell
- gene expression
- high resolution
- oxidative stress
- genome wide
- cerebral ischemia
- poor prognosis
- dna methylation
- ischemia reperfusion injury
- white matter
- high fat diet induced
- mass spectrometry
- physical activity
- climate change
- subarachnoid hemorrhage
- rheumatoid arthritis
- anti inflammatory
- multiple sclerosis
- amyotrophic lateral sclerosis
- metabolic syndrome
- depressive symptoms
- transcription factor
- big data
- resting state
- blood brain barrier
- tandem mass spectrometry
- deep learning